PDCD1 and neoplasm: Specifically, this process reversed the functional inhibition of T lymphocytes by inhibiting the programmed death-ligand 1 (PD-L1)/programmed cell death protein 1 (PD-1) axis between tumor-associated macrophages and T lymphocytes [84].